6分钟步行试验预测非小细胞肺癌术后心肺并发症的预后价值
本研究基于前瞻性CATCH-LUNG队列,评估6分钟步行试验(6MWT)对接受肺叶切除术且肺功能中度下降的非小细胞肺癌(NSCLC)患者术后30天内心肺并发症的预测价值。按预测术后肺功能分为低危和中危组,再按6分钟步行距离分为短距离(<400 m)和长距离(≥400 m)组。结果显示中危/短距离组术后心肺并发症风险显著增高,而中危/长距离组与低危/长距离组无差异,提示6MWT可辅助识别适合手术的患者。
要点
- 中危/短距离组术后心肺并发症风险显著高于低危/长距离组(调整OR 7.84)。
- 中危/长距离组与低危/长距离组术后并发症无显著差异。
- 6MWT可提供额外信息以优化NSCLC肺叶切除术候选者。
核心结论
- 中危/短距离的NSCLC患者术后心肺并发症风险更高。
- 中危/长距离患者行肺叶切除术与低危/长距离患者相比可能可行。
- 6MWT可为NSCLC肺叶切除术候选者的筛选提供额外信息。
研究设计与样本
- 研究数据来自前瞻性队列研究CATCH-LUNG。
- 纳入接受肺叶切除术的NSCLC患者,按预测术后肺功能分为低危组和中危组。
- 每组再按6分钟步行距离分为短距离(<400 m)和长距离(≥400 m)组。
- 主要终点为术后30天内 postoperative cardiopulmonary complications 发生率。
- 采用多变量logistic回归模型比较四组间术后心肺并发症。
主要发现
- 中危/短距离组相对低危/长距离组,任何术后肺部并发症调整OR为10.26(95% CI, 2.37-44.36)。
- 中危/短距离组相对低危/长距离组,术后心脏并发症调整OR为5.65(95% CI, 1.39-22.90)。
- 中危/短距离组相对低危/长距离组,术后心肺并发症调整OR为7.84(95% CI, 2.24-27.46)。
- 中危/长距离组与低危/长距离组术后并发症无差异。
- 中危组内,短距离组相对长距离组术后心肺并发症调整OR为4.95(95% CI, 1.37-17.93)。
关键数值与推荐
- 6分钟步行距离分组阈值:短距离<400 m,长距离≥400 m。
- 肺功能分组依据预测术后肺功能分为低危组和中危组。
- 术后心肺并发症观察窗口为术后30天内。
临床怎么用
- 对肺功能中度下降的NSCLC肺叶切除术候选者,可结合6MWT结果进行风险分层。
- 6分钟步行距离<400 m且预测术后肺功能中危者,术后心肺并发症风险较高,需加强围手术期评估与监护。
- 6分钟步行距离≥400 m的中危患者,行肺叶切除术的术后并发症风险与低危/长距离者相近。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The risk stratification value of the 6-min walk test (6MWT) to decide the feasibility of surgical resection is not well elucidated in patients with non-small cell lung cancer (NSCLC) and moderately decreased lung function. OBJECTIVE: This study aimed to determine the role of the 6MWT in predicting postoperative cardiopulmonary complications in patients with NSCLC who underwent lobectomy and had moderately decreased lung function. METHODS: The data were obtained from a prospective cohort study called Coordinate Approach to Cancer Patient's Health for Lung Cancer (CATCH-LUNG). Patients who underwent lobectomy for NSCLC were classified into two groups according to predicted postoperative pulmonary function (low-risk group or moderate-risk group); each group was then further classified into short-distance (< 400 m) or long-distance (≥ 400 m) groups according to a 6-min walk distance. The main end point of this study was the incidence of postoperative cardiopulmonary complications occurring within the first 30 postoperative days. A multivariable logistic regression model was used to compare the postoperative cardiopulmonary complications among the four groups. RESULTS: The adjusted ORs for any postoperative pulmonary complications, postoperative cardiac complications, and postoperative cardiopulmonary complications in patients with moderate-risk/short-distance relative to those with low-risk/long-distance were 10.26 (95% CI, 2.37-44.36), 5.65 (95% CI, 1.39-22.90), and 7.84 (95% CI, 2.24-27.46), respectively. However, these complications were not different between the patients with moderate-risk/long-term distance and those with low-risk/long-distance. Among patients in the moderate-risk group, those in the short-distance group had a significantly higher risk of postoperative cardiopulmonary complications compared with those in the long-distance group (adjusted OR, 4.95; 95% CI, 1.37-17.93). CONCLUSIONS: Patients with NSCLC with moderate-risk/short-distance were at greater risk of developing postoperative cardiopulmonary complications; it may be feasible, however, for patients with NSCLC and moderate-risk/long-distance to undergo lobectomy compared with those with low-risk/long-distance. Our study suggests that the 6MWT could provide additional information in identifying optimal candidates for lung resection surgery of NSCLC. TRIAL REGISTRY: ClinicalTrials.gov; No.: NCT03705546; URL: www.clinicaltrials.gov.
引用
- Lee H, Kim HK, Kang D, et al. Prognostic Value of 6-Min Walk Test to Predict Postoperative Cardiopulmonary Complications in Patients With Non-small Cell Lung Cancer. Chest. 2020. PMID: 31987880. doi:10.1016/j.chest.2019.12.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。